Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | +10.00% | +12.10% | +211.50% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
323M | - | |||||
684B | ||||||
568B | ||||||
361B | ||||||
329B | ||||||
284B |
- Stock Market
- Equities
- NKTR Stock
- Charts Nektar Therapeutics
- Sector Chart